[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"prognostic-model\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:prognostic-model":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,42],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":4,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":30,"lastUpdatePostDateStruct":31,"startDateStruct":34,"completionDateStruct":36,"leadSponsor":38,"locationsCount":41},"100531233","mri-based-signatures-for-survival-prediction-in-cervical-cancer-with-radiotherapy-100531233",false,"NCT06197126","MRI-based Signatures for Survival Prediction in Cervical Cancer With Radiotherapy","A Prognostic Model Based on MRI for Cervical Cancer Patients Treated With Radiotherapy","Inclusion Criteria:\n\n* (1) pathologically confirmed CC, (2) initially treated in our center\n\nExclusion Criteria:\n\n* (1) lack of pre-treatment MRI, (2) prior anti-tumor treatment, (3) pelvic surgery history, (4) incomplete therapy, (5) loss of follow-up","FEMALE","20 Years","85 Years",{"count":20,"type":21},200,"ESTIMATED","OBSERVATIONAL","This study aims to validate the value of tumor involvement features based on MRI in cervical cancer, facilitate the development of a more appropriate model for risk stratification, and help patients with varying risk profiles make appropriate decisions in treatment selection and follow-up plans.",[25,26,27,28],"Cervical Cancer","Radiotherapy","Prognostic Model","MRI","NOT_YET_RECRUITING","2023-12-25",{"date":32,"type":33},"2024-01-09","ACTUAL",{"date":35,"type":21},"2024-01-01",{"date":37,"type":21},"2028-12-31",{"name":39,"class":40},"Fujian Cancer Hospital","OTHER_GOV",1,{"id":43,"slug":44,"hasResults":11,"nctId":45,"briefTitle":46,"officialTitle":47,"acronym":4,"eligibilityCriteria":48,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":49,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":51,"conditions":52,"keywords":4,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":55,"lastUpdatePostDateStruct":56,"startDateStruct":58,"completionDateStruct":60,"leadSponsor":62,"locationsCount":41},"100523919","a-predictive-model-for-early-metastasis-in-cervical-cancer-patients-after-radiotherapy-100523919","NCT06101966","A Predictive Model for Early Metastasis in Cervical Cancer Patients After Radiotherapy","A Novel Predictive Model and Risk Stratification for Early Metastasis in Cervical Cancer Patients After Radiotherapy","Inclusion Criteria:\n\n* patients confirmed as cervical cancer by biopsies and treated with radiotherapy were initially enrolled\n\nExclusion Criteria:\n\n* (1) patients treated with surgery. (2) patient received incomplete treatment somewhere else. (3) patients with cancer history. (4) patients with pelvic surgery history. (5) patients without complete pre-treatment medical information. (6) patients with unfinished radical radiotherapy. (7) patients suffered from metastasis within 3 months after radiotherapy. (8) patients without complete 1-year follow-up materials",{"count":50,"type":21},500,"This study aims to help to screen out appropriate cases for consolidation therapy and more intensive follow up.",[25,26,53,27,54],"Distant Metastasis","Risk Factor","2023-10-21",{"date":57,"type":33},"2023-10-26",{"date":59,"type":21},"2023-12-01",{"date":61,"type":21},"2027-12-01",{"name":39,"class":40}]